转运和抑制机制为VMAT2介导的突触囊泡载荷的单胺
Yuwei Wang1,2, Pei Zhang3, Yulin Chao1,2
1Shanghai Stomatological Hospital, School of Stomatology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
膀单胺转运体2 (VMAT2) 结构揭示了它如何结合血清素和诸如甲的抑制剂. 这些发现为神经精神疾病和药物设计提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 膀单胺转运体2 (VMAT2) 对于储存诸如血清素和多巴胺之类的单胺神经递质在突触囊中至关重要.
- 功能障碍的VMAT2与各种神经精神疾病有关.
- 包括reserpine和tetrabenazine在内的VMAT2抑制剂在临床上用于高血压和运动障碍等疾病.
研究的目的:
- 阐明VMAT2基质识别和抑制剂结合的结构基础.
- 了解运输和抑制过程中VMAT2的动态构造变化.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定人体ApoVMAT2和VMAT2与血清素,四贝纳和保留素结合的结构.
- 为了补充结构数据,进行了生物化学分析.
主要成果:
- 捕获了三个不同的VMAT2构造:面向光层,封闭和面向细胞质.
- 贝纳结合诱导了TM2和TM7跨膜螺旋体的显著重新排列,超过了典型的形状变化.
- 确定了参与连接体识别和质子驱动的传输周期的关键结构元素.
结论:
- 确定的结构为VMAT2的作用和抑制机制提供了前所未有的洞察力.
- 这种结构框架可以指导开发针对VMAT2的神经精神疾病的新疗法.
更多相关视频
06:18Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons
Published on: April 3, 2014
09:33An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins
Published on: June 26, 2018
相关概念视频
Neurochemical Transmission: Sites of Drug Action
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Fusion of Secretory Vesicles with the Plasma Membrane
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drugs Affecting Neurotransmitter Synthesis
